TABLE 2

Distribution of gender, age, comorbidity, source of infection, and outcome between health care- and community-associated infectionsa

CharacteristicTotal (n = 129)Health care associated (n = 81)Community associated (n = 48)P value
Gender
    Male73 (56.6)44 (54.3)29 (60.4)0.496
Age (yr)
    Mean ± SD49.99 ± 24.9051.35 ± 28.1347.70 ± 18.260.423
    0–1715 (11.6)13 (16.0)2 (4.2)0.041b
        <110 (7.8)10 (12.3)00.011b
    18–6476 (58.9)37 (45.7)39 (81.3)<0.001c
    ≥6538 (29.5)31 (38.3)7 (14.6)0.004d
Comorbidity
    Diabetes mellitus38 (29.5)32 (39.5)6 (12.5)0.001d
    End-stage renal disease32 (24.8)32 (37.5)0<0.001c
    Liver cirrhosis6 (4.7)6 (7.4)00.054
    Solid-organ malignancy19 (14.7)18 (22.2)1 (2.1)0.002d
    Hematologic malignancy2 (1.6)2 (2.5)00.271
    Cerebrovascular accident18 (14.0)14 (17.3)4 (8.3)0.156
Source of infection
    Skin and soft tissue57 (44.2)16 (19.8)41 (85.4)<0.001c
    Unknown source of bacteremia30 (23.3)28 (34.6)2 (4.2)<0.001c
    Catheter-related bloodstream infection10 (7.8)10 (12.3)00.011b
    Bone and joints8 (6.2)7 (8.6)1 (2.1)0.136
    Arteriovenous fistula/graft6 (4.7)6 (7.4)00.053
    Infective endocarditis5 (3.9)3 (3.7)2 (4.2)0.986
    Intra-abdomen4 (3.1)4 (4.9)00.119
    Genital system3 (2.3)2 (2.5)1 (2.1)0.889
    Peritoneal dialysis-related peritonitis2 (1.6)2 (2.5)00.271
    Lung1 (0.8)1 (1.2)00.441
    Central nervous system1 (0.8)1 (1.2)00.441
    Deep neck1 (0.8)1 (1.2)00.441
    Sinusitis1 (0.8)1 (1.2)00.441
14-day all-cause mortality9 (7.0)9 (11.1)00.017b
  • a All data are presented as the no. (%), unless otherwise stated.

  • b P < 0.05.

  • c P < 0.001.

  • d P < 0.01.